THE SCIENCE OF PLANTABLE
Wellness trends fade.
Science never goes out of style.
Big Food. Big Problem.
It's not our fault
Today’s modern diet—filled with added sugars, refined grains, and processed ingredients—satisfies our tastebuds, not our appetites.
The simple fix
The solution isn’t to eat less, but to switch what we eat in favor of whole foods and real, unprocessed ingredients.
No more dieting. No more calorie counting. Just a happy weight, improved metabolic health, and long-lasting, healthier habits.
The simple science
Plantable effortlessly moves you into the real-food cycle
Long term impact.
Plantable is a 28-day, coach-supported program based upon the widely accepted science that a whole-food, plant-based diet, with the reduction of sugar, is optimal for health and wellness. When we adopt a Plantable diet our bodies aren’t constantly craving nutrients and crashing from blood sugar (and dopamine or insulin) spikes, resulting in measurable differences we can see and feel.
Plantable brings together nutritional science & behavioral science
to put you back in control
Plant-based nutrition, for real
- HEALTHY VEGAN
- FULLY PREPARED
- READY IN MINUTES
- MACRO-NUTRIENT BALANCED
- SERIOUSLY TASTY
HIGH IN FIBER
NO INFLAMMATORY OILS
NO ADDED SUGAR
We’ve got your back
Today's modern diet triggers cravings, known to sabotage even our best intentions. Your personal coach will get to know you, your routine, and your habits in order to bring you the support and tools to reset those cravings and replace them with new, healthier habits.
Our app brings you all the additional tools you’ll need to
easily maintain your new lifestyle!
Rooted in science
Plantable’s Foundational Results have formed the basis of clinical trials with leading medical institutions—including Memorial Sloan Kettering, Weill Cornell, and Johns Hopkins—to independently assess Plantable as a dietary intervention (through our signature combination of whole food, plant-based meals, personalized coaching, and lifestyle platform) on risk factors independently linked to breast, myeloma, and prostate cancer (currently in pipeline).
Primary outcomes of these trials include weight loss, improvement in the microbiome, reduction in inflammatory tissue, and changes in gene expression. Secondary outcomes include markers associated with metabolic health including the reduction of cholesterol, blood sugar, blood pressure and inflammation.
We expect to begin to announce the results of our trials in late 2022.
& Clinical Investigators
Dr. Hooman Yaghoobzadeh
Chief medical advisor
Chief nutrition advisor
Dr. Dexter Shurney
Chief insurance advisor
Clinical trial principal investigators
Dr. Neil Iyengar MD
Breast cancer trial collaborator (MSKCC)
Dr. David Nanus MD
Prostate cancer trial collaborator (Weill Cornell)
Dr. Urvi Shah MD
Myeloma cancer trial collaborator (MSKCC)